From: High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study
Variable | Crude HR (95% CI) | P value | Adjusted HR (95% CI) | p value |
---|---|---|---|---|
Age group (years) | ||||
 15–24 | 1 |  | 1 |  |
 25–34 | 1 · 62 (1 · 01–2 · 58) |  | 1 · 18 (0 · 73–1 · 89) |  |
 35–44 | 1 · 57 (0 · 97–2 · 53) |  | 1 · 07 (0 · 65–1 · 77) |  |
 45–54 | 3 · 79 (2 · 37–6 · 07) |  | 2 · 37 (1 · 44–3 · 92) |  |
 55–64 | 1 · 85 (0 · 96–3 · 57) |  | 1 · 43 (0 · 73–2 · 80) |  |
  > 65 | 3 · 60 (2 · 03–6 · 38) | <0 · 001 | 1 · 64 (0 · 90–2 · 99) | 0.001 |
Gender | ||||
 Female | 1 | 0 · 06 | 1 |  |
 Male | 1 · 28 (0 · 99–1 · 67) |  | 0 · 94 (0 · 71–1 · 25) | 0 · 68 |
Residence | ||||
 Within Kano | 1 |  | 1 |  |
 Outside Kano | 6. · 74 (5 · 13–8 · 86) | <0 · 001 | 3 · 18 (2 · 28–4 · 45) | <0 · 001 |
Referral facility | ||||
 DOTS-linked facility | 1 |  | 1 |  |
 Non DOTS-linked facility | 5 · 85 (4 · 07–8 · 42) | <0 · 001 | 3 · 02 (2 · 01–4 · 53) | <0 · 001 |
TB diagnosis | ||||
 Bacteriological | 1 |  | 1 |  |
 Clinical | 10 · 72 (6 · 12–18 · 76) | <0 · 001 | 4 · 96 (2 · 69–9 · 17) | <0 · 001 |
TB site | ||||
 Pulmonary | 1 |  | 1 |  |
 Extra-pulmonary | 1 · 46 (1 · 00–2 · 14) |  | 1 · 08 (0 · 72–1 · 63) |  |
 Both | 4 · 86 (3 · 68–6 · 42) | <0 · 001 | 1 · 45 (1 · 03–2 · 02) | 0 · 09 |
HIV/ART status | ||||
 HIV- | 1 |  | 1 |  |
 HIV+ on ART | 0 · 43 (0 · 21–0 · 92) |  | 1 · 51 (0 · 60–3 · 78) |  |
 HIV+ not on ART | 1 · 42 (1 · 09–1 · 86) |  | 1 · 39 (1 · 04–1 · 85) |  |
 Unknown HIV status | 0 · 54 (0 · 32–0 · 93) | <0 · 001 | 0 · 77 (0 · 44–1 · 33) | 0 · 05 |
Previous TB treatment | ||||
 No | 1 |  | 1 |  |
 Yes | 6 · 43 (4 · 95–8 · 35) | <0 · 001 | 3 · 48 (2 · 54–4 · 77) | <0 · 001 |
Year of diagnosis | ||||
 2010–2011 | 1 |  | 1 |  |
 2012 | 1 · 17 (0 · 86–1 · 60) |  | 1 · 10 (0 · 78–1 · 56) |  |
 2013 | 0 · 48 (0 · 36–0 · 68) |  | 0 · 47 (0 · 32–0 · 69) |  |
 2014 | 0 · 45 (0 · 29–0 · 70) | <0 · 001 | 0 · 45 (0 · 27–0 · 74) | <0 · 001 |